 | • レポートコード：D0GIR-06210 • 出版社/出版日：GlobalInfoResearch / 2020年9月18日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、馬狂犬病免疫グロブリン（ERIG）の世界市場を広く調査・分析し、今後の市場展望をまとめております。馬狂犬病免疫グロブリン（ERIG）の種類別市場規模（1500IU、1000IU、400IU、その他）、用途別市場規模（カテゴリーII暴露、カテゴリーIII暴露）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Serum China、Premium Serums、Lanzhou Institute of Biological Products、Wuhan Institute of Biological Products、Bharat Serums、Haffkine Bio-Pharmaceutical ・地域別グローバル市場分析 2015年-2020年 ・馬狂犬病免疫グロブリン（ERIG）の北米市場（アメリカ、カナダ、メキシコ） ・馬狂犬病免疫グロブリン（ERIG）のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・馬狂犬病免疫グロブリン（ERIG）のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・馬狂犬病免疫グロブリン（ERIG）の南米市場（ブラジル、アルゼンチン） ・馬狂犬病免疫グロブリン（ERIG）の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：1500IU、1000IU、400IU、その他 ・用途別分析：カテゴリーII暴露、カテゴリーIII暴露 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The Equine Rabies Immunoglobulin (ERIG) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The most likely (base case) scenario is that the global Equine Rabies Immunoglobulin (ERIG) sales will be xx in 2020 from Equine Rabies Immunoglobulin (ERIG) million in 2019, with a change xx% between 2019 and 2020. In addition, based on the latest study, it is to predict that the Covid-19 will be under control in key countries like the United States, Western Europe, East Asia, by the end of Q2 (June), and will resume normal production in Q3 and Q4, the global Equine Rabies Immunoglobulin (ERIG) market size is expected to grow at xx% or more annually for the next five years.
This report also researches and evaluates the impact of Covid-19 outbreak on the Equine Rabies Immunoglobulin (ERIG) industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on Equine Rabies Immunoglobulin (ERIG) and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).
Market segmentation
Equine Rabies Immunoglobulin (ERIG) market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Equine Rabies Immunoglobulin (ERIG) market has been segmented into
1500IU
1000IU
400IU
Other
By Application, Equine Rabies Immunoglobulin (ERIG) has been segmented into:
Category II Exposure
Category III Exposure
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Equine Rabies Immunoglobulin (ERIG) market presented in the report. This section sheds light on the sales growth of different regional and country-level Equine Rabies Immunoglobulin (ERIG) markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Equine Rabies Immunoglobulin (ERIG) market.
The report offers in-depth assessment of the growth and other aspects of the Equine Rabies Immunoglobulin (ERIG) market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Equine Rabies Immunoglobulin (ERIG) Market Share Analysis
Equine Rabies Immunoglobulin (ERIG) competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Equine Rabies Immunoglobulin (ERIG) sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Equine Rabies Immunoglobulin (ERIG) sales, revenue and market share for each player covered in this report.
The major players covered in Equine Rabies Immunoglobulin (ERIG) are:
Serum China
Premium Serums
Lanzhou Institute of Biological Products
Wuhan Institute of Biological Products
Bharat Serums
Haffkine Bio-Pharmaceutical
Among other players domestic and global, Equine Rabies Immunoglobulin (ERIG) market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Equine Rabies Immunoglobulin (ERIG) product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Equine Rabies Immunoglobulin (ERIG), with price, sales, revenue and global market share of Equine Rabies Immunoglobulin (ERIG) in 2018 and 2019.
Chapter 3, the Equine Rabies Immunoglobulin (ERIG) competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Equine Rabies Immunoglobulin (ERIG) breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Equine Rabies Immunoglobulin (ERIG) market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Equine Rabies Immunoglobulin (ERIG) sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Equine Rabies Immunoglobulin (ERIG) Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Equine Rabies Immunoglobulin (ERIG) Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 1500IU
1.2.3 1000IU
1.2.4 400IU
1.2.5 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Equine Rabies Immunoglobulin (ERIG) Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Category II Exposure
1.3.3 Category III Exposure
1.4 Overview of Global Equine Rabies Immunoglobulin (ERIG) Market
1.4.1 Global Equine Rabies Immunoglobulin (ERIG) Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
1.6 COVID-19 Outbreak: Equine Rabies Immunoglobulin (ERIG) Industry Impact
1.6.1 COVID-19 Potential Implications for the Equine Rabies Immunoglobulin (ERIG)
1.6.1.1 Scenario One: Very Optimistic: COVID-19 has No Influence on Equine Rabies Immunoglobulin (ERIG)
1.6.1.2 Scenario Two: Optimistic: COVID-19 Will Be Under Control by the End of April
1.6.1.3 Scenario Three: Gloomy: COVID-19 Will Be Under Control Between Q3 and Q4
1.6.1.4 Scenario Four: Most Likely: COVID-19 Will Be Under Control by the End of Q2
1.6.2 Opportunity Analysis in Covid-19 Crisis
1.6.3 Market Risk and Restraints
1.6.4 Market Driving Force
2 Manufacturers Profiles
2.1 Serum China
2.1.1 Serum China Details
2.1.2 Serum China Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Serum China SWOT Analysis
2.1.4 Serum China Product and Services
2.1.5 Serum China Equine Rabies Immunoglobulin (ERIG) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Premium Serums
2.2.1 Premium Serums Details
2.2.2 Premium Serums Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Premium Serums SWOT Analysis
2.2.4 Premium Serums Product and Services
2.2.5 Premium Serums Equine Rabies Immunoglobulin (ERIG) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Lanzhou Institute of Biological Products
2.3.1 Lanzhou Institute of Biological Products Details
2.3.2 Lanzhou Institute of Biological Products Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Lanzhou Institute of Biological Products SWOT Analysis
2.3.4 Lanzhou Institute of Biological Products Product and Services
2.3.5 Lanzhou Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Wuhan Institute of Biological Products
2.4.1 Wuhan Institute of Biological Products Details
2.4.2 Wuhan Institute of Biological Products Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Wuhan Institute of Biological Products SWOT Analysis
2.4.4 Wuhan Institute of Biological Products Product and Services
2.4.5 Wuhan Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Bharat Serums
2.5.1 Bharat Serums Details
2.5.2 Bharat Serums Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Bharat Serums SWOT Analysis
2.5.4 Bharat Serums Product and Services
2.5.5 Bharat Serums Equine Rabies Immunoglobulin (ERIG) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Haffkine Bio-Pharmaceutical
2.6.1 Haffkine Bio-Pharmaceutical Details
2.6.2 Haffkine Bio-Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Haffkine Bio-Pharmaceutical SWOT Analysis
2.6.4 Haffkine Bio-Pharmaceutical Product and Services
2.6.5 Haffkine Bio-Pharmaceutical Equine Rabies Immunoglobulin (ERIG) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Equine Rabies Immunoglobulin (ERIG) Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Equine Rabies Immunoglobulin (ERIG) Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Equine Rabies Immunoglobulin (ERIG) Manufacturer Market Share in 2019
3.3.2 Top 6 Equine Rabies Immunoglobulin (ERIG) Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Equine Rabies Immunoglobulin (ERIG) Sales, Revenue and Market Share by Regions
4.1.1 Global Equine Rabies Immunoglobulin (ERIG) Sales and Market Share by Regions (2015-2020)
4.1.2 Global Equine Rabies Immunoglobulin (ERIG) Revenue and Market Share by Regions (2015-2020)
4.2 North America Equine Rabies Immunoglobulin (ERIG) Sales and Growth Rate (2015-2020)
4.3 Europe Equine Rabies Immunoglobulin (ERIG) Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Equine Rabies Immunoglobulin (ERIG) Sales and Growth Rate (2015-2020)
4.5 South America Equine Rabies Immunoglobulin (ERIG) Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Equine Rabies Immunoglobulin (ERIG) Sales, Revenue and Market Share by Country
5.1.1 North America Equine Rabies Immunoglobulin (ERIG) Sales and Market Share by Country (2015-2020)
5.1.2 North America Equine Rabies Immunoglobulin (ERIG) Revenue and Market Share by Country (2015-2020)
5.2 United States Equine Rabies Immunoglobulin (ERIG) Sales and Growth Rate (2015-2020)
5.3 Canada Equine Rabies Immunoglobulin (ERIG) Sales and Growth Rate (2015-2020)
5.4 Mexico Equine Rabies Immunoglobulin (ERIG) Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Equine Rabies Immunoglobulin (ERIG) Sales, Revenue and Market Share by Country
6.1.1 Europe Equine Rabies Immunoglobulin (ERIG) Sales and Market Share by Country (2015-2020)
6.1.2 Europe Equine Rabies Immunoglobulin (ERIG) Revenue and Market Share by Country (2015-2020)
6.2 Germany Equine Rabies Immunoglobulin (ERIG) Sales and Growth Rate (2015-2020)
6.3 UK Equine Rabies Immunoglobulin (ERIG) Sales and Growth Rate (2015-2020)
6.4 France Equine Rabies Immunoglobulin (ERIG) Sales and Growth Rate (2015-2020)
6.5 Russia Equine Rabies Immunoglobulin (ERIG) Sales and Growth Rate (2015-2020)
6.6 Italy Equine Rabies Immunoglobulin (ERIG) Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Equine Rabies Immunoglobulin (ERIG) Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Equine Rabies Immunoglobulin (ERIG) Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Equine Rabies Immunoglobulin (ERIG) Revenue and Market Share by Regions (2015-2020)
7.2 China Equine Rabies Immunoglobulin (ERIG) Sales and Growth Rate (2015-2020)
7.3 Japan Equine Rabies Immunoglobulin (ERIG) Sales and Growth Rate (2015-2020)
7.4 Korea Equine Rabies Immunoglobulin (ERIG) Sales and Growth Rate (2015-2020)
7.5 India Equine Rabies Immunoglobulin (ERIG) Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Equine Rabies Immunoglobulin (ERIG) Sales and Growth Rate (2015-2020)
7.7 Australia Equine Rabies Immunoglobulin (ERIG) Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Equine Rabies Immunoglobulin (ERIG) Sales, Revenue and Market Share by Country
8.1.1 South America Equine Rabies Immunoglobulin (ERIG) Sales and Market Share by Country (2015-2020)
8.1.2 South America Equine Rabies Immunoglobulin (ERIG) Revenue and Market Share by Country (2015-2020)
8.2 Brazil Equine Rabies Immunoglobulin (ERIG) Sales and Growth Rate (2015-2020)
8.3 Argentina Equine Rabies Immunoglobulin (ERIG) Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Equine Rabies Immunoglobulin (ERIG) Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Equine Rabies Immunoglobulin (ERIG) Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Equine Rabies Immunoglobulin (ERIG) Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Equine Rabies Immunoglobulin (ERIG) Sales and Growth Rate (2015-2020)
9.3 Turkey Equine Rabies Immunoglobulin (ERIG) Sales and Growth Rate (2015-2020)
9.4 Egypt Equine Rabies Immunoglobulin (ERIG) Sales and Growth Rate (2015-2020)
9.5 South Africa Equine Rabies Immunoglobulin (ERIG) Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Equine Rabies Immunoglobulin (ERIG) Sales and Market Share by Type (2015-2020)
10.2 Global Equine Rabies Immunoglobulin (ERIG) Revenue and Market Share by Type (2015-2020)
10.3 Global Equine Rabies Immunoglobulin (ERIG) Price by Type (2015-2020)
11 Global Equine Rabies Immunoglobulin (ERIG) Market Segment by Application
11.1 Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Application (2015-2020)
11.2 Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Application (2015-2020)
11.3 Global Equine Rabies Immunoglobulin (ERIG) Price by Application (2015-2020)
12 Market Forecast
12.1 Global Equine Rabies Immunoglobulin (ERIG) Sales, Revenue and Growth Rate (2021-2025)
12.2 Equine Rabies Immunoglobulin (ERIG) Market Forecast by Regions (2021-2025)
12.2.1 North America Equine Rabies Immunoglobulin (ERIG) Market Forecast (2021-2025)
12.2.2 Europe Equine Rabies Immunoglobulin (ERIG) Market Forecast (2021-2025)
12.2.3 Asia-Pacific Equine Rabies Immunoglobulin (ERIG) Market Forecast (2021-2025)
12.2.4 South America Equine Rabies Immunoglobulin (ERIG) Market Forecast (2021-2025)
12.2.5 Middle East & Africa Equine Rabies Immunoglobulin (ERIG) Market Forecast (2021-2025)
12.3 Equine Rabies Immunoglobulin (ERIG) Market Forecast by Type (2021-2025)
12.3.1 Global Equine Rabies Immunoglobulin (ERIG) Sales Forecast by Type (2021-2025)
12.3.2 Global Equine Rabies Immunoglobulin (ERIG) Market Share Forecast by Type (2021-2025)
12.4 Equine Rabies Immunoglobulin (ERIG) Market Forecast by Application (2021-2025)
12.4.1 Global Equine Rabies Immunoglobulin (ERIG) Sales Forecast by Application (2021-2025)
12.4.2 Global Equine Rabies Immunoglobulin (ERIG) Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Equine Rabies Immunoglobulin (ERIG) Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Equine Rabies Immunoglobulin (ERIG) by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Equine Rabies Immunoglobulin (ERIG) Market Size and Growth Estimation in Various Scenarios in 2020
Table 4. Global Equine Rabies Immunoglobulin (ERIG) Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 5. Market Opportunities in Next Few Years
Table 6. Market Risks Analysis
Table 7. Market Drivers
Table 8. Serum China Basic Information, Manufacturing Base and Competitors
Table 9. Serum China Equine Rabies Immunoglobulin (ERIG) Major Business
Table 10. Serum China Equine Rabies Immunoglobulin (ERIG) Total Revenue (USD Million) (2018-2019)
Table 11. Serum China SWOT Analysis
Table 12. Serum China Equine Rabies Immunoglobulin (ERIG) Product and Services
Table 13. Serum China Equine Rabies Immunoglobulin (ERIG) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 14. Premium Serums Basic Information, Manufacturing Base and Competitors
Table 15. Premium Serums Equine Rabies Immunoglobulin (ERIG) Major Business
Table 16. Premium Serums Equine Rabies Immunoglobulin (ERIG) Total Revenue (USD Million) (2018-2019)
Table 17. Premium Serums SWOT Analysis
Table 18. Premium Serums Equine Rabies Immunoglobulin (ERIG) Product and Services
Table 19. Premium Serums Equine Rabies Immunoglobulin (ERIG) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 20. Lanzhou Institute of Biological Products Basic Information, Manufacturing Base and Competitors
Table 21. Lanzhou Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Major Business
Table 22. Lanzhou Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Total Revenue (USD Million) (2018-2019)
Table 23. Lanzhou Institute of Biological Products SWOT Analysis
Table 24. Lanzhou Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Product and Services
Table 25. Lanzhou Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 26. Wuhan Institute of Biological Products Basic Information, Manufacturing Base and Competitors
Table 27. Wuhan Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Major Business
Table 28. Wuhan Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Total Revenue (USD Million) (2018-2019)
Table 29. Wuhan Institute of Biological Products SWOT Analysis
Table 30. Wuhan Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Product and Services
Table 31. Wuhan Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 32. Bharat Serums Basic Information, Manufacturing Base and Competitors
Table 33. Bharat Serums Equine Rabies Immunoglobulin (ERIG) Major Business
Table 34. Bharat Serums Equine Rabies Immunoglobulin (ERIG) Total Revenue (USD Million) (2018-2019)
Table 35. Bharat Serums SWOT Analysis
Table 36. Bharat Serums Equine Rabies Immunoglobulin (ERIG) Product and Services
Table 37. Bharat Serums Equine Rabies Immunoglobulin (ERIG) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 38. Haffkine Bio-Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 39. Haffkine Bio-Pharmaceutical Equine Rabies Immunoglobulin (ERIG) Major Business
Table 40. Haffkine Bio-Pharmaceutical Equine Rabies Immunoglobulin (ERIG) Total Revenue (USD Million) (2018-2019)
Table 41. Haffkine Bio-Pharmaceutical SWOT Analysis
Table 42. Haffkine Bio-Pharmaceutical Equine Rabies Immunoglobulin (ERIG) Product and Services
Table 43. Haffkine Bio-Pharmaceutical Equine Rabies Immunoglobulin (ERIG) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 44. Global Equine Rabies Immunoglobulin (ERIG) Sales by Manufacturer (2018-2019) (K Units)
Table 45. Global Equine Rabies Immunoglobulin (ERIG) Revenue by Manufacturer (2018-2019) (USD Million)
Table 46. Global Equine Rabies Immunoglobulin (ERIG) Sales by Regions (2015-2020) (K Units)
Table 47. Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Regions (2015-2020)
Table 48. Global Equine Rabies Immunoglobulin (ERIG) Revenue by Regions (2015-2020) (USD Million)
Table 49. North America Equine Rabies Immunoglobulin (ERIG) Sales by Countries (2015-2020) (K Units)
Table 50. North America Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Countries (2015-2020)
Table 51. North America Equine Rabies Immunoglobulin (ERIG) Revenue by Countries (2015-2020) (USD Million)
Table 52. North America Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Countries (2015-2020)
Table 53. Europe Equine Rabies Immunoglobulin (ERIG) Sales by Countries (2015-2020) (K Units)
Table 54. Europe Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Countries (2015-2020)
Table 55. Europe Equine Rabies Immunoglobulin (ERIG) Revenue by Countries (2015-2020) (USD Million)
Table 56. Asia-Pacific Equine Rabies Immunoglobulin (ERIG) Sales by Regions (2015-2020) (K Units)
Table 57. Asia-Pacific Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Regions (2015-2020)
Table 58. Asia-Pacific Equine Rabies Immunoglobulin (ERIG) Revenue by Regions (2015-2020) (USD Million)
Table 59. South America Equine Rabies Immunoglobulin (ERIG) Sales by Countries (2015-2020) (K Units)
Table 60. South America Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Countries (2015-2020)
Table 61. South America Equine Rabies Immunoglobulin (ERIG) Revenue by Countries (2015-2020) (USD Million)
Table 62. South America Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Countries (2015-2020)
Table 63. Middle East & Africa Equine Rabies Immunoglobulin (ERIG) Sales by Countries (2015-2020) (K Units)
Table 64. Middle East & Africa Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Countries (2015-2020)
Table 65. Middle East & Africa Equine Rabies Immunoglobulin (ERIG) Revenue by Countries (2015-2020) (USD Million)
Table 66. Middle East & Africa Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Countries (2015-2020)
Table 67. Global Equine Rabies Immunoglobulin (ERIG) Sales by Type (2015-2020) (K Units)
Table 68. Global Equine Rabies Immunoglobulin (ERIG) Sales Share by Type (2015-2020)
Table 69. Global Equine Rabies Immunoglobulin (ERIG) Revenue by Type (2015-2020) (USD Million)
Table 70. Global Equine Rabies Immunoglobulin (ERIG) Revenue Share by Type (2015-2020)
Table 71. Global Equine Rabies Immunoglobulin (ERIG) Sales by Application (2015-2020) (K Units)
Table 72. Global Equine Rabies Immunoglobulin (ERIG) Sales Share by Application (2015-2020)
Table 73. Global Equine Rabies Immunoglobulin (ERIG) Sales Forecast by Regions (2021-2025) (K Units)
Table 74. Global Equine Rabies Immunoglobulin (ERIG) Market Share Forecast by Regions (2021-2025)
Table 75. Global Equine Rabies Immunoglobulin (ERIG) Sales Forecast by Type (2021-2025) (K Units)
Table 76. Global Equine Rabies Immunoglobulin (ERIG) Market Share Forecast by Type (2021-2025)
Table 77. Global Equine Rabies Immunoglobulin (ERIG) Sales Forecast by Application (2021-2025)
Table 78. Global Equine Rabies Immunoglobulin (ERIG) Market Share Forecast by Application (2021-2025)
Table 79. Direct Channel Pros & Cons
Table 80. Indirect Channel Pros & Cons
Table 81. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Equine Rabies Immunoglobulin (ERIG) Picture
Figure 2. Global Sales Market Share of Equine Rabies Immunoglobulin (ERIG) by Type in 2019
Figure 3. 1500IU Picture
Figure 4. 1000IU Picture
Figure 5. 400IU Picture
Figure 6. Other Picture
Figure 7. Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Application in 2018
Figure 8. Category II Exposure Picture
Figure 9. Category III Exposure Picture
Figure 10. Global Equine Rabies Immunoglobulin (ERIG) Market Status and Outlook (2015-2025) (USD Million)
Figure 11. United States Equine Rabies Immunoglobulin (ERIG) Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Canada Equine Rabies Immunoglobulin (ERIG) Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Mexico Equine Rabies Immunoglobulin (ERIG) Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Germany Equine Rabies Immunoglobulin (ERIG) Revenue (Value) and Growth Rate (2015-2025)
Figure 15. France Equine Rabies Immunoglobulin (ERIG) Revenue (Value) and Growth Rate (2015-2025)
Figure 16. UK Equine Rabies Immunoglobulin (ERIG) Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Russia Equine Rabies Immunoglobulin (ERIG) Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Italy Equine Rabies Immunoglobulin (ERIG) Revenue (Value) and Growth Rate (2015-2025)
Figure 19. China Equine Rabies Immunoglobulin (ERIG) Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Japan Equine Rabies Immunoglobulin (ERIG) Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Korea Equine Rabies Immunoglobulin (ERIG) Revenue (Value) and Growth Rate (2015-2025)
Figure 22. India Equine Rabies Immunoglobulin (ERIG) Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Southeast Asia Equine Rabies Immunoglobulin (ERIG) Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Australia Equine Rabies Immunoglobulin (ERIG) Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 25. Brazil Equine Rabies Immunoglobulin (ERIG) Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Egypt Equine Rabies Immunoglobulin (ERIG) Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Saudi Arabia Equine Rabies Immunoglobulin (ERIG) Revenue (Value) and Growth Rate (2015-2025)
Figure 28. South Africa Equine Rabies Immunoglobulin (ERIG) Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Turkey Equine Rabies Immunoglobulin (ERIG) Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Manufacturer in 2019
Figure 31. Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Manufacturer in 2019
Figure 32. Top 3 Equine Rabies Immunoglobulin (ERIG) Manufacturer (Revenue) Market Share in 2019
Figure 33. Top 6 Equine Rabies Immunoglobulin (ERIG) Manufacturer (Revenue) Market Share in 2019
Figure 34. Key Manufacturer Market Share Trend
Figure 35. Global Equine Rabies Immunoglobulin (ERIG) Sales and Growth Rate (2015-2020) (K Units)
Figure 36. Global Equine Rabies Immunoglobulin (ERIG) Revenue and Growth Rate (2015-2020) (USD Million)
Figure 37. Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Regions (2015-2020)
Figure 38. Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Regions in 2018
Figure 39. North America Equine Rabies Immunoglobulin (ERIG) Sales and Growth Rate (2015-2020)
Figure 40. Europe Equine Rabies Immunoglobulin (ERIG) Sales and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Equine Rabies Immunoglobulin (ERIG) Sales and Growth Rate (2015-2020)
Figure 42. South America Equine Rabies Immunoglobulin (ERIG) Sales and Growth Rate (2015-2020)
Figure 43. Middle East & Africa Equine Rabies Immunoglobulin (ERIG) Sales and Growth Rate (2015-2020)
Figure 44. North America Equine Rabies Immunoglobulin (ERIG) Revenue and Growth Rate (2015-2020) (USD Million)
Figure 45. North America Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Countries (2015-2020)
Figure 46. North America Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Countries in 2018
Figure 47. North America Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 48. North America Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Countries in 2018
Figure 49. United States Equine Rabies Immunoglobulin (ERIG) Sales and Growth Rate (2015-2020) (K Units)
Figure 50. Canada Equine Rabies Immunoglobulin (ERIG) Sales and Growth Rate (2015-2020) (K Units)
Figure 51. Mexico Equine Rabies Immunoglobulin (ERIG) Sales and Growth Rate (2015-2020) (K Units)
Figure 52. Europe Equine Rabies Immunoglobulin (ERIG) Revenue and Growth Rate (2015-2020) (USD Million)
Figure 53. Europe Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Countries (2015-2020)
Figure 54. Europe Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Countries in 2019
Figure 55. Germany Equine Rabies Immunoglobulin (ERIG) Sales and Growth Rate (2015-2020) (K Units)
Figure 56. UK Equine Rabies Immunoglobulin (ERIG) Sales and Growth Rate (2015-2020) (K Units)
Figure 57. France Equine Rabies Immunoglobulin (ERIG) Sales and Growth Rate (2015-2020) (K Units)
Figure 58. Russia Equine Rabies Immunoglobulin (ERIG) Sales and Growth Rate (2015-2020) (K Units)
Figure 59. Italy Equine Rabies Immunoglobulin (ERIG) Sales and Growth Rate (2015-2020) (K Units)
Figure 60. Asia-Pacific Equine Rabies Immunoglobulin (ERIG) Revenue and Growth Rate (2015-2020) (USD Million)
Figure 61. Asia-Pacific Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Regions 2019
Figure 62. Asia-Pacific Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Regions 2019
Figure 63. China Equine Rabies Immunoglobulin (ERIG) Sales and Growth Rate (2015-2020) (K Units)
Figure 64. Japan Equine Rabies Immunoglobulin (ERIG) Sales and Growth Rate (2015-2020) (K Units)
Figure 65. Korea Equine Rabies Immunoglobulin (ERIG) Sales and Growth Rate (2015-2020) (K Units)
Figure 66. India Equine Rabies Immunoglobulin (ERIG) Sales and Growth Rate (2015-2020) (K Units)
Figure 67. Southeast Asia Equine Rabies Immunoglobulin (ERIG) Sales and Growth Rate (2015-2020) (K Units)
Figure 68. South America Equine Rabies Immunoglobulin (ERIG) Revenue and Growth Rate (2015-2020) (USD Million)
Figure 69. South America Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Countries in 2019
Figure 70. South America Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Countries in 2019
Figure 71. Brazil Equine Rabies Immunoglobulin (ERIG) Sales and Growth Rate (2015-2020) (K Units)
Figure 72. Argentina Equine Rabies Immunoglobulin (ERIG) Sales and Growth Rate (2015-2020) (K Units)
Figure 73. Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Revenue and Growth Rate (2015-2020) (USD Million)
Figure 74. Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Countries in 2019
Figure 75. Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Countries (2015-2020)
Figure 76. Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Countries in 2019
Figure 77. Saudi Arabia Equine Rabies Immunoglobulin (ERIG) Sales and Growth Rate (2015-2020) (K Units)
Figure 78. Egypt Equine Rabies Immunoglobulin (ERIG) Sales and Growth Rate (2015-2020) (K Units)
Figure 79. Turkey Equine Rabies Immunoglobulin (ERIG) Sales and Growth Rate (2015-2020) (K Units)
Figure 80. South Africa Equine Rabies Immunoglobulin (ERIG) Sales and Growth Rate (2015-2020) (K Units)
Figure 81. Global Equine Rabies Immunoglobulin (ERIG) Sales and Growth Rate (2021-2025) (K Units)
Figure 82. Global Equine Rabies Immunoglobulin (ERIG) Revenue and Growth Rate (2021-2025) (USD Million)
Figure 83. North America Sales Equine Rabies Immunoglobulin (ERIG) Market Forecast (2021-2025) (K Units)
Figure 84. Europe Sales Equine Rabies Immunoglobulin (ERIG) Market Forecast (2021-2025) (K Units)
Figure 85. Asia-Pacific Sales Equine Rabies Immunoglobulin (ERIG) Market Forecast (2021-2025) (K Units)
Figure 86. South America Sales Equine Rabies Immunoglobulin (ERIG) Market Forecast (2021-2025) (K Units)
Figure 87. Middle East & Africa Sales Equine Rabies Immunoglobulin (ERIG) Market Forecast (2021-2025) (K Units)
Figure 88. Sales Channel: Direct Channel vs Indirect Channel
狂犬病モノクローナル抗体の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Rabies Monoclonal Antibody market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimiza…- 狂犬病免疫グロブリンの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The Rabies Immune Globulin market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization…
- 狂犬病抗血清の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The Rabies Antiserum market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trad…
- ヒト狂犬病免疫グロブリン（HRIG）の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The Human Rabies Immune Globulin (HRIG) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain…
- ヒト正常免疫グロブリンの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The Human Normal Immunoglobulin market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimiz…